Lack of occult hepatitis B virus infection among blood donors with isolated hepatitis B core antibody living in an HBV low prevalence region of Iran

International Journal of Infectious Diseases

Volumn 14, Issue 4, 2010, Pages

  Sofian, Masoomeh ^a   Aghakhani, Arezoo ^b   Izadi, Nabiallah ^c   Banifazl, Mohammad ^d   Kalantar, Ebrahim ^e   Eslamifar, Ali ^b   Ramezani, Amitis ^b  

^a ARAK UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b PASTEUR INSTITUTE OF IRAN   (Iran)

^c IRANIAN BLOOD TRANSFUSION ORGANIZATION   (Iran)

^d Iranian Society for Support of Patients with Infectious Diseases   (Iran)

^e IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Blood donor; Isolated hepatitis B core antibody (anti HBc); Occult hepatitis B virus (HBV) infection

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; VIRUS DNA;

ADOLESCENT; ADULT; ARTICLE; BLOOD DONOR; BLOODSTREAM INFECTION; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; SEROPREVALENCE; VIRUS ISOLATION;

ADOLESCENT; ADULT; BLOOD DONORS; CHI-SQUARE DISTRIBUTION; DNA, VIRAL; FEMALE; HEPATITIS B; HEPATITIS B CORE ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; IRAN; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PREVALENCE; YOUNG ADULT;

EID: 77949488763     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijid.2009.05.011     Document Type: Article

References (39)

1. Lee W.M., and Hepatitis. B virus infection. N Engl J Med 337 (1997) 1733-1745
2. Liu C.J., Chen D.S., and Chen P.J. Epidemiology of HBV infection in Asian blood donors: emphasis on occult HBV infection and the role of NAT. J Clin Virol 36 Suppl 1 (2006) S33-44
3. Raimondo G., Pollicino T., Cacciola I., and Squadrito G. Occult hepatitis B virus infection. J Hepatol 46 (2007) 160-170
4. Henning H., Puchta I., Luhm J., Schlenke P., Goerg S., and Kirchner H. Frequency and load of hepatitis B virus DNA in first-time blood donors with antibodies to hepatitis B core antigen. Blood 100 (2002) 2637-2641
5. Dreier J., Kroger M., Diekmann C., Gotting C., and Kleesiek K. Low-level viremia of hepatitis B virus in an anti-HBc- and anti-HBs-positive blood donor. Transfus Med 14 (2004) 97-103
6. Grob P., Jilg W., Bornhak H., Gerken G., Gerlich W., Gunther S., et al. Serological pattern 'anti-HBc alone': report on a workshop. J Med Virol 62 (2000) 450-455
7. Lok A.S., Lai C.L., and Wu P.C. Prevalence of isolated antibody to hepatitis B core antigen in an area endemic for hepatitis B virus infection: implications in hepatitis B vaccination programs. Hepatology 8 (1988) 766-770
8. Gandhi R.T., Wurcel A., Lee H., McGovern B., Boczanowski M., Gerwin R., et al. Isolated antibody to hepatitis B core antigen in human immunodeficiency virus type-1-infected individuals. Clin Infect Dis 36 (2003) 1602-1605
9. Brechot C., Thiers V., Kremsdorf D., Nalpas B., Pol S., and Paterlini-Brechot P. Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely 'occult'?. Hepatology 34 (2001) 194-203
10. Conjeevaram H.S., and Lok A.S. Occult hepatitis B virus infection: a hidden menace?. Hepatology 34 (2001) 204-206
11. Allain J.P. Occult hepatitis B virus infection: implications in transfusion. Vox Sang 86 (2004) 83-91
12. Alavian S.M., Fallahian F., and Lankarani K.B. The changing epidemiology of viral hepatitis B in Iran. J Gastrointestin Liver Dis 16 (2007) 403-406
13. Merat S., Malekzadeh R., Rezvan H., and Khatibian M. Hepatitis B in Iran. Arch Iran Med 3 (2000) 192-201
14. Aghakhani A., Hamkar R., Zamani N., Eslamifar A., Banifazl M., Saadat A., et al. Hepatitis B virus genotype in Iranian patients with hepatocellular carcinoma. Int J Infect Dis (2009) [Epub ahead of print]
15. Fani A., Fani I., Eshrati B., Samadian P., Fani P., Gorishi Y., et al. Screening for hepatocellular carcinoma in chronic carriers of hepatitis B and C in Markazi Province. Iran. Hepatitis Monthly 7 (2007) 149-152
16. Matsumoto C., Tadokoro K., Fujimura K., Hirakawa S., Mitsunaga S., and Juji T. Analysis of HBV infection after blood transfusion in Japan through investigation of a comprehensive donor specimen repository. Transfusion 41 (2001) 878-884
17. Kleinman S.H., and Busch M.P. HBV: amplified and back in the blood safety spotlight. Transfusion 41 (2001) 1081-1085
18. Allain J.P., Candotti D., Soldan K., Sarkodie F., Phelps B., Giachetti C., et al. The risk of hepatitis B virus infection by transfusion in Kumasi, Ghana. Blood 101 (2003) 2419-2425
19. Kleinman S.H., Kuhns M.C., Todd D.S., Glynn S.A., McNamara A., DiMarco A., et al. Frequency of HBV-DNA detection in US blood donors testing positive for the presence of anti-HBc: implication for transfusion transmission and donor screening. Transfusion 43 (2003) 696-704
20. Zervou E.K., Dalekos G.N., Boumba D.S., and Tsianos E.V. Value of anti-HBc screening of blood donors for prevention of HBV infection: results of a 3-year prospective study in northwestern Greece. Transfusion 41 (2001) 652-658
21. Bernvill S.S., Andrews V., Kuhns M.C., and McNamara A.L. Hepatitis B core antigen antibody as an indicator of a low grade carrier state for hepatitis B virus in a Saudi Arabian blood donor population. Transfus Sci 18 (1997) 49-53
22. Chemin I., Zoulim F., Merle P., Arkhis A., Chevallier M., Kay A., et al. High incidence of hepatitis B infection among chronic hepatitis cases of unknown aetiology. J Hepatol 34 (2001) 447-454
23. Raimondo G., Allain J.P., Brunetto M.R., Buendia M.A., Chen D.S., Colombo M., et al. Statements from the Taormina expert meeting on occult hepatitis B virus infection. J Hepatol 49 (2008) 652-657
24. Carman W.F. The clinical significance of surface antigen variants of hepatitis B virus. J Viral Hepat 4 Suppl 1 (1997) 11-20
25. Zuckerman A.J. Effect of hepatitis B virus mutants on efficacy of vaccination. Lancet 355 (2000) 1382-1384
26. Liang T.J., Blum H.E., and Wands J.R. Characterization and biological properties of a hepatitis B virus isolated from a patient without hepatitis B virus serologic markers. Hepatology 12 (1990) 204-212
27. Ackerman Z., Wands J.R., Gazitt Y., Brechot C., Kew M.C., and Shouval D. Enhancement of HBsAg detection in serum of patients with chronic liver disease following removal of circulating immune complexes. J Hepatol 20 (1994) 398-404
28. Hu K.Q. Occult hepatitis B virus infection and its clinical implications. J Viral Hepat 9 (2002) 243-257
29. Azadmanesh K., Mohraz M., Aghakhani A., Edalat R., Jam S., Eslamifar A., et al. Occult hepatitis B virus infection in HIV-infected patients with isolated hepatitis B core antibody. Intervirology 51 (2008) 270-274
30. Mphahlele M.J., Lukhwareni A., Burnett R.J., Moropeng L.M., and Ngobeni J.M. High risk of occult hepatitis B virus infection in HIV-positive patients from South Africa. J Clin Virol 35 (2006) 14-20
31. Gutierrez C., Leon G., Loureiro C.L., Uzcategui N., Liprandi F., Pujol F.H., and Hepatitis. B virus DNA in blood samples positive for antibodies to core antigen and negative for surface antigen. Clin Diagn Lab Immunol 6 (1999) 768-770
32. Ren F., Li H., and Zhao H. Studies on hepatitis B virus infection in blood donors with positive anti-HBc and negative HBsAg. Zhonghua Yu Fang Yi Xue Za Zhi 32 (1998) 7-9
33. Manzini P., Girotto M., Borsotti R., Giachino O., Guaschino R., Lanteri M., et al. Italian blood donors with anti-HBc and occult hepatitis B virus infection. Haematologica 92 (2007) 1664-1670
34. Kupski C., Träsel F.R., Mazzoleni F., Winckler M.A., Bender A.L., Machado D.C., et al. Serologic and molecular profile of anti-HBc-positive blood bank donors in an area of low endemicity for HBV. Dig Dis Sci 53 (2008) 1370-1374
35. El-Zayadi A.R., Ibrahim E.H., Badran H.M., Saeid A., Moneib N.A., Shemis M.A., et al. Anti-HBc screening in Egyptian blood donors reduces the risk of hepatitis B virus transmission. Transfus Med 18 (2008) 55-61
36. García-Montalvo B.M., Farfán-Ale J.A., Acosta-Viana K.Y., and Puerto-Manzano F.I. Hepatitis B virus DNA in blood donors with anti-HBc as a possible indicator of active hepatitis B virus infection in Yucatan, Mexico. Transfus Med 15 (2005) 371-378
37. Duseja A., Sharma S., Subramanian P.G., Agnihotri S.K., Chakraborti A., and Chawla Y. Occult hepatitis B virus (HBV) infection in healthy blood donors. Indian J Pathol Microbiol 46 (2003) 690-692
38. Kaminski G., Alnaqdy A., Al-Belushi I., Nograles J., and Al-Dhahry S.H. Evidence of occult hepatitis B virus infection among Omani blood donors: a preliminary study. Med Princ Pract 15 (2006) 368-372
39. Behzad-Behbahani A., Mafi-Nejad A., Tabei S.Z., Lankarani K.B., Torab A., and Moaddeb A. Anti-HBc and HBV-DNA detection in blood donors negative for hepatitis B virus surface antigen in reducing risk of transfusion associated HBV infection. Indian J Med Res 123 (2006) 37-42